Department of Psychiatry, University of Michigan, Ann Arbor, MI; Department of Veterans Affairs, HSR&D Center for Clinical Management Research (CCMR), and Serious Mental Illness Treatment, Resource and Evaluation Center (SMITREC), Ann Arbor, MI.
Am J Geriatr Psychiatry. 2013 Oct;21(10):999-1009. doi: 10.1016/j.jagp.2013.01.046. Epub 2013 Feb 6.
Although antidepressants are an effective treatment for later-life depression, older patients often choose not to initiate or to discontinue medication treatment prematurely. Although racial differences in depression treatment preferences have been reported, little is known about racial differences in antidepressant medication adherence among older patients.
Prospective, observational study comparing antidepressant adherence for older African American and white primary care patients.
A total of 188 subjects age 60 and older, diagnosed with clinically significant depression with a new recommendation for antidepressant treatment by their primary care physician.
Study participants were assessed at study entry and at the 4-month follow-up (encompassing the acute treatment phase). Depression medication adherence was based on a well-validated self-report measure.
At the 4-month follow-up, 61.2% of subjects reported that they were adherent to their antidepressant medication. In unadjusted and two of the three adjusted analyses, African American subjects (n = 82) had significantly lower rates of 4-month antidepressant adherence than white subjects (n = 106). African American women had the lowest adherence rates (44.4%) followed by African American men (56.8%), white men (65.3%), and white women (73.7%). In logistic regression models controlling for demographic, illness, and functional status variables, significant differences persisted between African American women and white women in reported 4-month antidepressant adherence (OR: 3.58, 95% CI: 1.27-10.07, Wald χ(2) = 2.42, df = 1, p <0.02).
The results demonstrate racial and gender differences in antidepressant adherence in older adults. Depression treatment interventions for older adults should take into account the potential impact of race and gender on adherence to prescribed medications.
尽管抗抑郁药是治疗老年抑郁症的有效方法,但老年患者常常选择不开始或过早停止药物治疗。尽管已经报道了不同种族在抑郁治疗偏好方面的差异,但对于老年患者中抗抑郁药物依从性的种族差异知之甚少。
比较老年非裔美国人和白人初级保健患者抗抑郁药物依从性的前瞻性、观察性研究。
共有 188 名年龄在 60 岁及以上的患者,被诊断为患有临床显著的抑郁症,他们的初级保健医生建议新的抗抑郁药物治疗。
研究参与者在研究开始时和 4 个月的随访时进行评估(包括急性治疗阶段)。抑郁药物依从性基于经过充分验证的自我报告测量。
在 4 个月的随访中,61.2%的患者报告他们坚持服用抗抑郁药物。在未调整和三个调整分析中的两个分析中,非裔美国患者(n=82)的 4 个月抗抑郁药物依从率明显低于白人患者(n=106)。非裔美国女性的依从率最低(44.4%),其次是非裔美国男性(56.8%)、白人男性(65.3%)和白人女性(73.7%)。在控制人口统计学、疾病和功能状态变量的逻辑回归模型中,非裔美国女性和白人女性在报告的 4 个月抗抑郁药物依从率方面存在显著差异(OR:3.58,95%CI:1.27-10.07,Wald χ²=2.42,df=1,p<0.02)。
结果表明,老年患者在抗抑郁药物依从性方面存在种族和性别差异。针对老年人的抑郁治疗干预措施应考虑种族和性别对遵医嘱服药的潜在影响。